Athira Pharma is a clinical stage drug development company. Founded by Joseph Harding, Leen Kawas in 2011, Athira Pharma is backed by investors that include Avidity Partners, Suzanne Kayne, Rick Kayne, Viking Global Investors, and Franklin Templeton Investments and is headquartered in Seattle.